Centessa Pharmaceuticals plc

Symbol: CNTA

NASDAQ

9.55

USD

Market price today

  • -6.1766

    P/E Ratio

  • 1.4380

    PEG Ratio

  • 943.30M

    MRK Cap

  • 0.00%

    DIV Yield

Centessa Pharmaceuticals plc (CNTA) Stock Split, History Data

Working capital analysis

In terms of working capital, Centessa Pharmaceuticals plc maintains a healthy position. The total current assets of the company are valued at $315092000. This represents a growth rate of -19.955% compared to the previous year. Breaking down the current assets, the cash and investments are worth $128030000, exhibiting a growth rate of -67.476% year-on-year. The receivables, another significant portion of the current assets, are valued at $39148000. The year-on-year growth rate for receivables is 46.496%. The inventory, which forms a critical part of the assets, is valued at $1. This represents a healthy year-on-year growth of -100.000% On the liabilities side, the company's current liabilities total $39385000. This reflects a growth rate of 2.731% over the previous year, indicating the company's financial obligations are well under control.

2023202220212020
Cash and investments
128.03
393.64
595.08
7.23
Receavebles
39.15
26.72
16.81
2.93
Inventory
0.00
29.99
17.81
1.00
Other
19.39
3.27
0.99
0.01
Total Current Assets
315.09
393.64
595.08
11.16
Acc Payable
11.81
13.84
8.06
1.03
Short Term Debt
0.00
0.00
0.00
5.63
Other Current Liab
27.57
24.50
16.57
0.92
Current Liabilities
39.38
38.34
24.64
8.62

Capital Structure

When examining the capital structure of Centessa Pharmaceuticals plc, it is clear that the company manages a robust portfolio. These earnings represent the profits that Centessa Pharmaceuticals plc has chosen to reinvest in the business rather than distribute as dividends.

Total Assets

$NaN

Total liabilities

$NaN

Long term debt

$NaN

Cash and eqv

$NaN

Goodwill

$NaN

Retained earnings

$NaN

Common stock

$NaN

Enterprise Value

-$5.88

Frequently Asked Question

What is the latest historical split date of the company?

The latest historical split date is N/A.

What is firm free cah flow per share (FCF per share)?

The free cah flow per share (FCF per share) is -1.640.

What is company revenue per share?

The company revenue per share is -24.823.

What are firm earnings per share?

The firm earnings per share is 0.858.

What is Centessa Pharmaceuticals plc (CNTA) ROIC (return on capital)?

Centessa Pharmaceuticals plc (CNTA) ROIC (return on capital) is -0.530.

What is dividend per share figure?

The dividend per share is 0.000

What is enterprise plowback ratio?

Centessa Pharmaceuticals plc (CNTA) plowback ratio is N/A

What is firm enterprise value (EV)?

The enterprise value (EV) is -5.881

What is company debt to equity ratio?

The debt to equity ratio is 0.320

What are debt ratio numbers?

The debt ratio is 0.209

What is company price to sales ratio?

The price to sales ratio is 136.461